JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharif, N. A.
Right arrow Articles by Williams, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharif, N. A.
Right arrow Articles by Williams, G. W.

Vol. 293, Issue 2, 321-328, May 2000

Affinities, Selectivities, Potencies, and Intrinsic Activities of Natural and Synthetic Prostanoids Using Endogenous Receptors: Focus on DP Class Prostanoids

Najam A. Sharif, Julie Y. Crider, Shouxi X. Xu and Gary W. Williams

Molecular Pharmacology Unit, Alcon Research, Ltd., Fort Worth, Texas

The prostanoid receptor-subtype binding affinities, selectivities, potencies, and intrinsic activities of four natural prostanoids and six synthetic DP class prostanoids were determined using binding and functional assays with endogenous receptors. SQ27986 exhibited the highest affinity for the human platelet DP receptor and the best DP receptor selectivity profile. Prostaglandin (PG)D2 was the least DP receptor-selective. The rank order of compound affinities at the DP receptor was SQ27986 (Ki = 10 ± 2 nM) > RS93520 = ZK110841 = BW245C (Ki = 23-26 nM) > ZK118182 (Ki = 50 ± 9 nM) > PGD2 (Ki = 80 ± 5 nM). DP receptor agonists produced cAMP in embryonic bovine tracheal fibroblasts with different potencies (EC50 values in nM): ZK118182 (18 ± 6), RS93520 (28 ± 6), SQ27986 (29 ± 7), ZK110841 (31 ± 7), BW245C (53 ± 16), and PGD2 (98 ± 10). BW245C was more efficacious and RS93520 was less efficacious than PGD2. ZK110841 and ZK118182 exhibited a relatively high potency at the adenylyl cyclase-coupled EP2 receptor in human nonpigmented ciliary epithelial cells but were partial agonists. None of the DP class agonists showed any EP4 receptor functional activity in Chinese hamster ovary cells. The DP receptor antagonist BWA868C competitively antagonized the PGD2-induced cAMP accumulation in embryonic bovine tracheal fibroblast cells (pA2 = 7.83 ± 0.08). The dissociation constants for BWA868C antagonizing PGD2-, BW245C-, and ZK118182-induced cAMP production were quite similar (apparent -log Kb = 7.9-8.2, n = 5-9). The pharmacological properties of some natural and numerous DP class synthetic prostanoids have been determined using endogenous receptors.


0022-3565/00/2932-0321$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Schratl, J. F. Royer, E. Kostenis, T. Ulven, E. M. Sturm, M. Waldhoer, G. Hoefler, R. Schuligoi, I. Th. Lippe, B. A. Peskar, et al.
The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking
J. Immunol., October 1, 2007; 179(7): 4792 - 4799.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Mohri, M. Taniike, H. Taniguchi, T. Kanekiyo, K. Aritake, T. Inui, N. Fukumoto, N. Eguchi, A. Kushi, H. Sasai, et al.
Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher.
J. Neurosci., April 19, 2006; 26(16): 4383 - 4393.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Kohyama, T. A. Wyatt, X. Liu, F.-Q. Wen, T. Kobayashi, Q. Fang, H. J. Kim, and S. I. Rennard
PGD2 Modulates Fibroblast-Mediated Native Collagen Gel Contraction
Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 375 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Arimura, K. Yasui, J. Kishino, F. Asanuma, H. Hasegawa, S. Kakudo, M. Ohtani, and H. Arita
Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 411 - 419.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.